As 'philanthropic gesture' Covishield price reduced from Rs 400-Rs 300 for states: Adar Poonawalla

This follows widespread criticism of its pricing policy as it had sold the initial doses of Covishield to the central government at Rs 150 per dose.

Serum Institute of India’s CEO, Adar Poonawalla, on Wednesday, announced that Covishield’s price for states will be slashed from Rs 400 to Rs 300 as a philanthropic gesture.

As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives.

— Adar Poonawalla (@adarpoonawalla) April 28, 2021

Taking to Twitter, Poonawalla said, "As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives."

Covishield’s price for private hospitals remains at Rs 600 per dose.

This follows widespread criticism of its pricing policy as it had sold the initial doses of Covishield to the central government at Rs 150 per dose.

Both Bharat Biotech and Serum’s vaccines are available to the central government at a rate of Rs 150 per dose.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!